Keith Harrington
Co-Founder & COO @ Novel Capital
Kansas City, United States
Keith Harrington is a venture - series unknown investor at Novel Capital in Kansas City focused on Consulting and Health Care. Keith is Co-Founder and Managing Director of Novel Growth Partners, a revenue based financing firm in Kansas City. Keith launched Novel with his partner, Carlos Antequera in 2017 to provide entrepreneurs additional options in funding their growth. Prior to that, Keith was a co-founder at Fulcrum Global Capital, an agtech VC firm, and was managingdirector at Kansas Bioscience Authority, where he invested in early stage life sciences companies. Before that, Keith held various positions in operations, corporate development and M&A in a telecom startup that achieved $300M in revenue. Keith is a Kauffman Fellow, writes a newsletter about revenue based financing and was the lead organizer for Alternative Capital Summit 2, which brought 100 practitioners from around the world together to advance the state of the alternative investment and revenue based financing field.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Keith Harrington invests in
Stages Keith Harrington invests in
Countries Keith Harrington invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Consulting 1 (100%)
- Health Care 1 (100%)
- Clinical Trials 1 (100%)
- Management Consulting 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Gobel Group is the leading consulting and technology firm working exclusively in healthcare philanthropy. | $2.3M / Venture - Series Unknown / Nov 01, 2019 |
About Novel Capital
Novel Capital’s fintech funding platform breaks down the traditional growth barriers faced by today’s B2B software companies. Their tech-first approach makes it easy for customers to leverage future recurring revenue for immediate access to non-dilutive capital. Paired with online data-driven insights and curated learning resources, the Novelplatform empowers entrepreneurs to capitalize on their momentum.
Novel Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Carlos Antequera
Co-Founder & CEO
|
|||
|
Keith Harrington
Co-Founder & COO
|
|||
Mark L. Yu
President and Owner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Keith Harrington invest in?
Keith Harrington invests primarily in Consulting, Health Care and Clinical Trials startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Keith Harrington?
Public channels for Keith Harrington include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Keith Harrington last invest?
The most recent investment recorded for Keith Harrington closed in Nov 2019. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
